Latest Period
Q2 2026
Security Snapshot
Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) Institutional Ownership
CUSIP: 22407B108
13F Institutional Holders and Ownership History from Q4 2022 to Q2 2026
Institutions Reporting
54
Shares (Excl. Options)
7,775,612
Price
$5.85
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- COYA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 7,775,612
- Total 13F value
- $45,450,388
- Portfolio coverage rank
- 0%
- Share change
- -353,191
- Value change
- -$1,705,330
- Number of holders
- 54
- Shares outstanding
- 23,172,091
- SEC-reported price per share
- $4.64
- Insider filing price
- $4.64
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COYA - Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 22407B108.
- 54 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 57 to 54 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $32,048,898 to $45,450,388.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 54 institutions filings for Q2 2026.
Security key
22407B108
Latest holder period
Q2 2026
13F holders
54
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
COYA full holder history
Coya Therapeutics, Inc. SEC filings
Coya Therapeutics, Inc. company facts
Coya Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 22407B108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
COYA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories, Inc. | 9.7% | $10,727,271 | 2,272,727 | Dr. Reddy's Laboratories, Inc. | 30 Jan 2026 | |||
| DME Capital Management, LP | 9.9% | $10,783,903 | 1,651,440 | DME Advisors GP, L.L.C. | 31 Dec 2024 | |||
| VANGUARD GROUP INC | 4.3% | $5,215,012 | 899,140 | The Vanguard Group | 31 Dec 2025 | |||
| HIRSCHMAN ORIN | 3.3% | -40% | $4,473,372 | -$2,009,428 | 764,679 | -31% | Orin Hirschman | 30 Jun 2026 |
As of 30 Jun 2026, 54 institutional investors reported holding 7,775,612 shares of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA). This represents 34% of the company’s total 23,172,091 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
32%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| DME Capital Management, LP | 10% | 2,335,540 | 0% | 0.35% | $13,662,909 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 842,220 | -0.32% | 0% | $4,926,987 |
| Alyeska Investment Group, L.P. | 3.5% | 800,000 | 0% | 0.01% | $4,680,000 |
| AIGH Capital Management LLC | 2.7% | 631,912 | -35% | 0.33% | $3,696,685 |
| CM Management, LLC | 1.7% | 400,000 | +6.7% | 1.5% | $2,340,000 |
| PRIVATE MANAGEMENT GROUP INC | 1.7% | 384,217 | +4.1% | 0.06% | $2,247,669 |
| MARSHALL WACE, LLP | 1.1% | 249,793 | +11% | 0% | $1,461,289 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.98% | 228,243 | -2.2% | 0% | $1,335,507 |
| RENAISSANCE TECHNOLOGIES LLC | 0.83% | 192,986 | +86% | 0% | $1,128,968 |
| Prosight Management, LP | 0.73% | 170,000 | -60% | 0.17% | $994,500 |
| DIMENSIONAL FUND ADVISORS LP | 0.67% | 155,917 | +63% | 0% | $913,036 |
| VANGUARD FIDUCIARY TRUST CO | 0.56% | 129,551 | -7.4% | 0% | $757,873 |
| JONES FINANCIAL COMPANIES LLLP | 0.48% | 110,910 | +147% | 0% | $610,005 |
| BlackRock, Inc. | 0.44% | 102,408 | +24% | 0% | $599,087 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.44% | 101,330 | 0% | 0.04% | $592,781 |
| JBF Capital, Inc. | 0.43% | 100,006 | 0% | 0.08% | $585,035 |
| ROYAL BANK OF CANADA | 0.4% | 93,414 | +598% | 0% | $546,000 |
| MORGAN STANLEY | 0.35% | 82,106 | -4.2% | 0% | $480,320 |
| STATE STREET CORP | 0.34% | 79,813 | 0% | 0% | $466,906 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.26% | 61,006 | +55% | 0% | $356,885 |
| NORTHERN TRUST CORP | 0.19% | 45,072 | +12% | 0% | $263,671 |
| XTX Topco Ltd | 0.18% | 41,401 | -13% | 0% | $242,196 |
| ADAR1 Capital Management, LLC | 0.18% | 40,900 | 0% | 0.01% | $239,265 |
| Long Corridor Asset Management Ltd | 0.17% | 38,766 | 0% | 0.07% | $226,781 |
| Cetera Investment Advisers | 0.15% | 34,000 | +13% | 0% | $198,900 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
15
Latest
Q2 2026
Rows shown
1-15 of 15
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 7,775,612 | $45,450,388 | -$1,705,330 | $5.85 | 54 |
| 2026 Q1 | 8,132,603 | $32,048,898 | -$1,369,168 | $3.94 | 57 |
| 2025 Q4 | 7,939,025 | $46,046,406 | +$18,480,971 | $5.80 | 58 |
| 2025 Q3 | 4,755,804 | $27,110,326 | +$1,543,439 | $5.70 | 35 |
| 2025 Q2 | 4,484,686 | $25,787,239 | -$1,022,977 | $5.75 | 33 |
| 2025 Q1 | 4,662,591 | $30,167,676 | +$1,480,613 | $6.47 | 26 |
| 2024 Q4 | 4,444,580 | $25,467,940 | +$6,454,839 | $5.73 | 26 |
| 2024 Q3 | 3,315,161 | $21,385,210 | +$304,078 | $6.45 | 19 |
| 2024 Q2 | 3,268,292 | $19,805,900 | -$932,467 | $6.06 | 19 |
| 2024 Q1 | 3,339,060 | $33,123,748 | +$5,311,359 | $9.92 | 19 |
| 2023 Q4 | 2,822,037 | $20,644,859 | +$10,288,077 | $7.41 | 20 |
| 2023 Q3 | 1,416,355 | $5,449,280 | +$229,488 | $3.84 | 14 |
| 2023 Q2 | 1,351,642 | $5,500,530 | +$1,016,457 | $4.07 | 13 |
| 2023 Q1 | 1,101,849 | $4,368,596 | +$41,079 | $3.97 | 7 |
| 2022 Q4 | 1,091,417 | $5,156,354 | +$5,156,354 | $4.74 | 4 |